News | July 10, 2013

Study Demonstrates Improved Monitoring of Patients at Risk for Cardiotoxicity Using EchoInsight for Cardio Oncology

Results indicate EchoInsight for Cardio Oncology is a high quality, efficient application for comprehensive assessment and serial comparison of left ventricle (LV) function

EchoInsight for Cardio Oncology Clinical Study Left Ventricle Function

July 10, 2013 — Epsilon Imaging Inc. announced a clinical study demonstrating EchoInsight for Cardio Oncology to be a high quality, efficient application for comprehensive assessment of left ventricle (LV) function. The study, presented at the ASE 2013 Scientific Sessions in Minneapolis, Minn., further indicated EchoInsight for Cardio Oncology facilitates monitoring of patients at risk for cardiotoxicity. EchoInsight for Cardio Oncology is a vendor neutral application designed to assist clinicians in improving confidence and workflow of study interpretation and reporting when monitoring oncology patients.

At ASE 2013, Jeanne DeCara, M.D., et al. from the University of Chicago Medicine presented, “Vendor Independent Software for Rapid Comprehensive Assessment of Changes in Left Ventricle Function During Serial Echocardiographic Studies.” The study analyzed serial comparison studies from 30 subjects. Ejection fraction (EF) and longitudinal strain were measured to monitor change in cardiac function. An experienced reader reviewed the studies on another commercially available solution, and an inexperienced reader used EchoInsight for Cardio Oncology for analysis. The inexperienced reader also completed analysis without EchoInsight for Cardio Oncology. Study results concluded that analysis and interpretation is faster using EchoInsight for Cardio Oncology when compared to the other commercial application, and offers consistent findings. EchoInsight for Cardio Oncology also slightly improved the inexperienced reader’s assessment of LV function change.

“Our study demonstrates EchoInsight for Cardio Oncology offers visualization and analysis that allows for quick, easy and accurate interpretation of LV function over time,” said DeCara. “EchoInsight is a promising software application that may assist in the follow-up of patients undergoing potentially cardiotoxic treatments, such as chemotherapy.”

For more information: www.epsilon-imaging.com

Related Content

Hitachi Medical Systems Europe Introduces Third-Generation Intelligent Vector Flow Mapping
News | Cardiovascular Ultrasound | December 07, 2018
Hitachi Medical Systems Europe introduced what it calls the next level of intelligent Vector Flow Mapping (iVFM) at...
GE Healthcare Unveils New Applications and Smart Devices Built on Edison Platform
Technology | Artificial Intelligence | December 05, 2018
GE Healthcare recently announced new applications and smart devices built on Edison – a platform that helps accelerate...
GE Healthcare Introduces Invenia ABUS 2.0
Technology | Ultrasound Women's Health | December 03, 2018
GE Healthcare recently launched the Invenia automated breast ultrasound (ABUS) 2.0 system in the United States. This...
Videos | Ultrasound Imaging | November 28, 2018
This is an example of the new Fetal HQ heart and vascular software from GE Healthcare for fetal ultrasound.
Clarius Mobile Health Announces Clarius AI Collective Intelligence Ultrasound Platform
News | Ultrasound Imaging | November 21, 2018
Clarius Mobile Health will announce a new collective intelligence ultrasound platform at this year's Radiological...
Civco Medical Solutions Introduces Envision Viral Barrier at RSNA 2018
News | Ultrasound Imaging | November 20, 2018
Civco Medical Solutions will present Envision, the next generation of ultrasound probe covers and scan pads, at the...
Bay Labs and Northwestern Medicine Enroll First Patient in AI Echocardiography Study
News | Cardiovascular Ultrasound | November 19, 2018
Medical artificial intelligence (AI) company Bay Labs and Northwestern Medicine announced that the first patient has...
QView Medical Showcases QVCAD for ABUS Exams at RSNA 2018
News | Ultrasound Women's Health | November 19, 2018
QView Medical will showcase QVCAD, the first U.S. Food and Drug Administration (FDA)-approved artificial intelligence (...
SuperSonic Imagine Introduces Aixplorer Mach 30 Ultrasound at The Liver Meeting
Technology | Ultrasound Imaging | November 14, 2018
SuperSonic Imagine recently exhibited at The Liver Meeting, held Nov. 9-13 in San Francisco, where the company...
New Robotic Arm System Optimizes Testing of Ultrasound Probes

Image courtesy of Esaote

News | Ultrasound Imaging | November 09, 2018
Medical imaging company Esaote and The BioRobotics Institute of Scuola Superiore Sant’Anna in Pisa, Italy, have...